Leigh M Howard1, Kathryn M Edwards1, Yuwei Zhu2, Carlos G Grijalva3, Wesley H Self4, Seema Jain5, Krow Ampofo6, Andrew T Pavia6, Sandra R Arnold7, Jonathan A McCullers7,8, Evan J Anderson9, Richard G Wunderink10, Derek J Williams1. 1. Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 2. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 3. Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 4. Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 5. Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 6. University of Utah Health Sciences Center, Salt Lake City, Utah, USA. 7. University of Tennessee Health Sciences Center, Memphis, Tennessee, USA. 8. St. Jude Children's Research Hospital, Memphis, Tennessee, USA. 9. Departments of Pediatrics and Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. 10. Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Abstract
BACKGROUND: Human metapneumovirus (HMPV) is a leading cause of respiratory tract infections. Few studies have compared the clinical characteristics and severity of HMPV-associated pneumonia with other pathogens. METHODS: Active, population-based surveillance was previously conducted for radiographically confirmed, community-acquired pneumonia hospitalizations among children and adults in 8 United States hospitals. Clinical data and specimens for pathogen detection were systematically collected. We described clinical features of all HMPV-associated pneumonia and, after excluding codetections with other pathogen types, we compared features of HMPV-associated pneumonia with other viral, atypical, and bacterial pneumonia and modeled the severity (mild, moderate, and severe) and length of stay using multivariable proportional odds regression. RESULTS: HMPV was detected in 298/2358 (12.6%) children and 88/2320 (3.8%) adults hospitalized with pneumonia and was commonly codetected with other pathogens (125/298 [42%] children and 21/88 [24%] adults). Fever and cough were the most common presenting symptoms of HMPV-associated pneumonia and were also common symptoms of other pathogens. After excluding codetections in children (n = 1778), compared to HMPV (reference), bacterial pneumonia exhibited increased severity (odds ratio [OR], 3.66; 95% confidence interval [CI], 1.43-9.40), respiratory syncytial virus (RSV; OR, 0.76; 95% CI, .59-.99) and atypical (OR, 0.39; 95% CI, .19-.81) infections exhibited decreased severity, and other viral pneumonia exhibited similar severity (OR, 0.88; 95% CI, .55-1.39). In adults (n = 2145), bacterial (OR, 3.74; 95% CI, 1.87-7.47) and RSV pneumonia (OR, 1.82; 95% CI, 1.32-2.50) were more severe than HMPV (reference), but all other pathogens had similar severity. CONCLUSIONS: Clinical features did not reliably distinguish HMPV-associated pneumonia from other pathogens. HMPV-associated pneumonia was less severe than bacterial and adult RSV pneumonia, but was otherwise as or more severe than other common pathogens.
BACKGROUND:Human metapneumovirus (HMPV) is a leading cause of respiratory tract infections. Few studies have compared the clinical characteristics and severity of HMPV-associated pneumonia with other pathogens. METHODS: Active, population-based surveillance was previously conducted for radiographically confirmed, community-acquired pneumonia hospitalizations among children and adults in 8 United States hospitals. Clinical data and specimens for pathogen detection were systematically collected. We described clinical features of all HMPV-associated pneumonia and, after excluding codetections with other pathogen types, we compared features of HMPV-associated pneumonia with other viral, atypical, and bacterial pneumonia and modeled the severity (mild, moderate, and severe) and length of stay using multivariable proportional odds regression. RESULTS:HMPV was detected in 298/2358 (12.6%) children and 88/2320 (3.8%) adults hospitalized with pneumonia and was commonly codetected with other pathogens (125/298 [42%] children and 21/88 [24%] adults). Fever and cough were the most common presenting symptoms of HMPV-associated pneumonia and were also common symptoms of other pathogens. After excluding codetections in children (n = 1778), compared to HMPV (reference), bacterial pneumonia exhibited increased severity (odds ratio [OR], 3.66; 95% confidence interval [CI], 1.43-9.40), respiratory syncytial virus (RSV; OR, 0.76; 95% CI, .59-.99) and atypical (OR, 0.39; 95% CI, .19-.81) infections exhibited decreased severity, and other viral pneumonia exhibited similar severity (OR, 0.88; 95% CI, .55-1.39). In adults (n = 2145), bacterial (OR, 3.74; 95% CI, 1.87-7.47) and RSV pneumonia (OR, 1.82; 95% CI, 1.32-2.50) were more severe than HMPV (reference), but all other pathogens had similar severity. CONCLUSIONS: Clinical features did not reliably distinguish HMPV-associated pneumonia from other pathogens. HMPV-associated pneumonia was less severe than bacterial and adult RSV pneumonia, but was otherwise as or more severe than other common pathogens.
Authors: Yange Zhang; Senthilkumar K Sakthivel; Anna Bramley; Seema Jain; Amber Haynes; James D Chappell; Weston Hymas; Noel Lenny; Anami Patel; Chao Qi; Krow Ampofo; Sandra R Arnold; Wesley H Self; Derek J Williams; David Hillyard; Evan J Anderson; Carlos G Grijalva; Yuwei Zhu; Richard G Wunderink; Kathryn M Edwards; Andrew T Pavia; Jonathan A McCullers; Dean D Erdman Journal: J Clin Microbiol Date: 2016-12-28 Impact factor: 5.948
Authors: Kyle Widmer; Yuwei Zhu; John V Williams; Marie R Griffin; Kathryn M Edwards; H Keipp Talbot Journal: J Infect Dis Date: 2012-04-23 Impact factor: 5.226
Authors: Daniel R Feikin; Wei Fu; Daniel E Park; Qiyuan Shi; Melissa M Higdon; Henry C Baggett; W Abdullah Brooks; Maria Deloria Knoll; Laura L Hammitt; Stephen R C Howie; Karen L Kotloff; Orin S Levine; Shabir A Madhi; J Anthony G Scott; Donald M Thea; Peter V Adrian; Martin Antonio; Juliet O Awori; Vicky L Baillie; Andrea N DeLuca; Amanda J Driscoll; Bernard E Ebruke; Doli Goswami; Ruth A Karron; Mengying Li; Susan C Morpeth; John Mwaba; James Mwansa; Christine Prosperi; Pongpun Sawatwong; Samba O Sow; Milagritos D Tapia; Toni Whistler; Khalequ Zaman; Scott L Zeger; Katherine L O' Brien; David R Murdoch Journal: Clin Infect Dis Date: 2017-06-15 Impact factor: 9.079
Authors: Leigh M Howard; Kathryn M Edwards; Yuwei Zhu; Marie R Griffin; Geoffrey A Weinberg; Peter G Szilagyi; Mary A Staat; Daniel C Payne; John V Williams Journal: J Pediatric Infect Dis Soc Date: 2018-05-15 Impact factor: 3.164